Found: 30
Select item for more details and to access through your institution.
Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 2413, doi. 10.2147/PPA.S182563
- By:
- Publication type:
- Article
Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 1785, doi. 10.2147/PPA.S170636
- By:
- Publication type:
- Article
Patient Perspectives and Experiences of Preventive Treatments and Self-Injectable Devices for Migraine: A Focus Group Study.
- Published in:
- Patient, 2022, v. 15, n. 1, p. 93, doi. 10.1007/s40271-021-00525-z
- By:
- Publication type:
- Article
Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2010, v. 35, n. 2, p. 581, doi. 10.1038/npp.2009.164
- By:
- Publication type:
- Article
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 9, p. 1080, doi. 10.1001/jamaneurol.2018.1212
- By:
- Publication type:
- Article
Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study.
- Published in:
- BMC Psychiatry, 2012, v. 12, n. 1, p. 222, doi. 10.1186/1471-244X-12-222
- By:
- Publication type:
- Article
Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder.
- Published in:
- BMC Psychiatry, 2010, v. 10, p. 89, doi. 10.1186/1471-244X-10-89
- By:
- Publication type:
- Article
Predictors of switching antipsychotic medications in the treatment of schizophrenia.
- Published in:
- BMC Psychiatry, 2010, v. 10, p. 75, doi. 10.1186/1471-244X-10-75
- By:
- Publication type:
- Article
Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis.
- Published in:
- BMC Psychiatry, 2009, v. 9, p. 1, doi. 10.1186/1471-244X-9-12
- By:
- Publication type:
- Article
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.
- Published in:
- Cephalalgia, 2021, v. 41, n. 3, p. 340, doi. 10.1177/0333102420966658
- By:
- Publication type:
- Article
Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials.
- Published in:
- Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 6, p. 834, doi. 10.1111/head.13508
- By:
- Publication type:
- Article
Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0951-2
- By:
- Publication type:
- Article
Dose Response and Atypical Antipsychotics in Schizophrenia.
- Published in:
- CNS Drugs, 2004, v. 18, n. 9, p. 597, doi. 10.2165/00023210-200418090-00005
- By:
- Publication type:
- Article
The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania.
- Published in:
- Bipolar Disorders, 2002, v. 4, n. 1, p. 43, doi. 10.1034/j.1399-5618.2002.40103.x
- By:
- Publication type:
- Article
Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study.
- Published in:
- Quality of Life Research, 2021, v. 30, n. 2, p. 455, doi. 10.1007/s11136-020-02632-0
- By:
- Publication type:
- Article
Benefit-Risk Assessment of Galcanezumab Versus Placebo for the Treatment of Episodic and Chronic Migraine Using the Metrics of Number Needed to Treat and Number Needed to Harm.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01222-w
- By:
- Publication type:
- Article
Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01215-9
- By:
- Publication type:
- Article
Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials.
- Published in:
- Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01148-9
- By:
- Publication type:
- Article
Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
- Published in:
- Journal of Headache & Pain, 2019, v. 20, n. 1, p. 1, doi. 10.1186/s10194-019-1024-x
- By:
- Publication type:
- Article
Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia.
- Published in:
- Neuropsychiatric Disease & Treatment, 2013, v. 9, p. 815, doi. 10.2147/NDT.S43574
- By:
- Publication type:
- Article
Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia.
- Published in:
- Neuropsychiatric Disease & Treatment, 2012, v. 8, p. 113, doi. 10.2147/NDT.S30268
- By:
- Publication type:
- Article